Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
27.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
01.09.21 | Novo Nordisk Buy | Deutsche Bank AG | |
20.08.21 | Novo Nordisk Outperform | Bernstein Research | |
17.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.08.21 | Novo Nordisk Buy | Deutsche Bank AG | |
06.08.21 | Novo Nordisk Outperform | Bernstein Research | |
05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.07.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
07.07.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
30.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
24.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
24.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
10.06.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.06.21 | Novo Nordisk Outperform | Bernstein Research | |
10.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.06.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
01.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
24.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
21.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
19.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
06.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.05.21 | Novo Nordisk overweight | Barclays Capital | |
05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
25.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
23.03.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung